OpenFilings

BridgeBio Pharma, Inc.

Form10-K

Report Period2024-12-31

Date Filed2025-02-20

Time Filed16:00:55

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-10.42
EX-21
EX-23.1
EX-31.1
EX-31.2
EX-31.3
EX-32.1
EX-32.2
EX-32.3
Filing on SEC Edgar